CXCR4: A new drug target in lung cancer
Friday, April 30, 2010 - 03:40
in Health & Medicine
Lung cancer patients whose tumours over-express a cell surface molecule called CXCR4 do significantly worse than those who do not, Canadian researchers have found. Their work, reported at the 2nd European Lung Cancer Conference in Geneva, highlights the exciting possibility that the molecule could soon become a new target for personalised cancer therapy...